Harbor Investment Advisory, LLC Halozyme Therapeutics, Inc. Transaction History

Harbor Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$37.81 - $52.4 $151 - $209	4 New	4 $0
Q1 2023 Apr 21, 2023	BUY	$32.86 - $55.7 $5,487 - $9,301	167 Added 9.81%	1,869 $71,000
Q1 2022 Apr 20, 2022	SELL	$31.97 - $41.06 $8,056 - $10,347	-252 Reduced 12.9%	1,702 $68,000
Q2 2021 Jul 27, 2021	BUY	$38.84 - $51.31 $7,690 - $10,159	198 Added 11.28%	1,954 $89,000
Q4 2020 Feb 04, 2021	BUY	$25.81 - $43.62 $16,776 - $28,353	650 Added 58.77%	1,756 $75,000
Q3 2020 Oct 23, 2020	BUY	$25.74 - $29.63 $28,468 - $32,770	1,106 New	1,106 $29,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.